137 related articles for article (PubMed ID: 17082489)
1. Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease.
Koyama H; Shoji T; Fukumoto S; Shinohara K; Shoji T; Emoto M; Mori K; Tahara H; Ishimura E; Kakiya R; Tabata T; Yamamoto H; Nishizawa Y
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):147-53. PubMed ID: 17082489
[TBL] [Abstract][Full Text] [Related]
2. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
Nishizawa Y; Koyama H
J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
[TBL] [Abstract][Full Text] [Related]
3. Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness.
Choi KM; Yoo HJ; Kim HY; Lee KW; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH
Int J Cardiol; 2009 Feb; 132(1):96-101. PubMed ID: 18190981
[TBL] [Abstract][Full Text] [Related]
4. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.
Postorino M; Marino C; Tripepi G; Zoccali C;
J Am Coll Cardiol; 2009 Apr; 53(15):1265-72. PubMed ID: 19358939
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.
Sahinarslan A; Güz G; Okyay K; Mutluay R; Yalçin R; Bali M; Sindel S; Cengel A
Turk Kardiyol Dern Ars; 2008 Sep; 36(6):382-7. PubMed ID: 19155641
[TBL] [Abstract][Full Text] [Related]
7. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis.
Roberts MA; Thomas MC; Fernando D; Macmillan N; Power DA; Ierino FL
Nephrol Dial Transplant; 2006 Jun; 21(6):1611-7. PubMed ID: 16520354
[TBL] [Abstract][Full Text] [Related]
9. Decreased serum esRAGE level is associated with angiographically determined coronary plaque progression in diabetic patients.
Peng WH; Lu L; Hu J; Yan XX; Zhang Q; Zhang RY; Chen QJ; Shen WF
Clin Biochem; 2009 Aug; 42(12):1252-9. PubMed ID: 19439163
[TBL] [Abstract][Full Text] [Related]
10. Circulating E-selectin as a risk marker in patients with end-stage renal disease.
Malatino LS; Stancanelli B; Cataliotti A; Bellanuova I; Fatuzzo P; Rapisarda F; Leonardis D; Tripepi G; Mallamaci F; Zoccali C
J Intern Med; 2007 Oct; 262(4):479-87. PubMed ID: 17875185
[TBL] [Abstract][Full Text] [Related]
11. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
[TBL] [Abstract][Full Text] [Related]
12. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.
Terrier N; Jaussent I; Dupuy AM; Morena M; Delcourt C; Chalabi L; Rouanet C; Canaud B; Cristol JP
Nephrol Dial Transplant; 2008 Jan; 23(1):345-53. PubMed ID: 17890748
[TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.
Kalousová M; Jáchymová M; Germanová A; Kubena AA; Tesar V; Zima T
Kidney Blood Press Res; 2010; 33(1):30-6. PubMed ID: 20185929
[TBL] [Abstract][Full Text] [Related]
14. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis.
Koyama H; Shoji T; Yokoyama H; Motoyama K; Mori K; Fukumoto S; Emoto M; Shoji T; Tamei H; Matsuki H; Sakurai S; Yamamoto Y; Yonekura H; Watanabe T; Yamamoto H; Nishizawa Y
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2587-93. PubMed ID: 16224056
[TBL] [Abstract][Full Text] [Related]
15. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
16. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure.
Johansson M; Gao SA; Friberg P; Annerstedt M; Carlström J; Ivarsson T; Jensen G; Ljungman S; Mathillas O; Nielsen FD; Strömbom U
J Hypertens; 2007 Jan; 25(1):163-8. PubMed ID: 17143188
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study.
Wang AY; Lam CW; Wang M; Chan IH; Yu CM; Lui SF; Sanderson JE
Am J Nephrol; 2008; 28(4):647-53. PubMed ID: 18292652
[TBL] [Abstract][Full Text] [Related]
18. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
19. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.
Norata GD; Garlaschelli K; Grigore L; Tibolla G; Raselli S; Redaelli L; Buccianti G; Catapano AL
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):129-34. PubMed ID: 18595673
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
